Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,563 across all filing types
Latest filing 2019-12-12 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
关于股东部分股份质押及解除质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the pledge and release of certain shareholders' shares as collateral for convertible bonds. It details the shareholders involved, the number of shares pledged and released, and the purpose of the pledge related to bond issuance. There is no financial statement, earnings data, or management discussion. The document is a regulatory disclosure about share pledges and changes in collateral arrangements, typical of announcements about share pledges or capital structure updates. It is not a full financial report, earnings release, or management report. The content fits best under Capital/Financing Update (CAP) as it concerns financing activities related to convertible bonds and share pledges.
2019-12-12 Chinese
关于独立董事取得独立董事资格证书的公告
Board/Management Information Classification · 95% confidence The document is a public announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding an independent director obtaining an independent director qualification certificate. It references board meetings and shareholder meetings where the director was elected, and the subsequent fulfillment of regulatory requirements by obtaining the certificate. The document is short (799 characters) and serves as an announcement of a compliance event rather than a detailed report or financial disclosure. It does not contain financial data, audit information, or detailed management discussion. It fits best under Board/Management Information (MANG) as it relates to board member qualifications and appointments.
2019-12-06 Chinese
中国证监会行政许可项目审查一次反馈意见通知书
Regulatory Filings
2019-12-03 Chinese
关于收到《中国证监会行政许可项目审查一次反馈意见通知书》的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding receipt of a feedback notice from the China Securities Regulatory Commission (CSRC) about their administrative licensing project review. It discusses the need to provide written explanations and submit responses within 30 working days. The document mentions ongoing regulatory review related to a major asset restructuring and the uncertainty of approval. There are no financial statements, detailed financial data, or report contents included. The document is short (771 characters) and serves as a regulatory update or announcement about the review process and next steps, not the actual report or detailed filing itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance update.
2019-12-03 Chinese
关于控股股东部分股份解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the release of pledged shares by the controlling shareholder of Zhejiang Huatong Pharmaceutical Co., Ltd. It details the number of shares released from pledge, the dates, and the pledgee information. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about share pledge status, which fits the category of Regulatory Filings (RNS) as it does not fit into more specific categories like share issue or director dealings. The document length is short and it is an announcement rather than a report.
2019-11-22 Chinese
关于公司启用新公章的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the company's use of a new official seal (公章). It does not contain financial data, management changes, voting results, or any report content. It is a regulatory announcement about administrative matters. The document length is only 405 characters, indicating it is a brief notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-11-14 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.